Tvardi Therapeutics, Inc. · BX:TVRD
Tvardi Therapeutics, Inc. shareholders
As of Sep 30, 2026, 60 institutions reported holding Tvardi Therapeutics, Inc., 27.1% of its shares. Largest: Slate Path Capital LP, Vanguard and Raymond James Financial Inc. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Tvardi Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Slate Path Capital LP | 704K | 5.3% | no change | Nov 16, 2026 |
| Vanguard | 420K | 3.1% | +27,322 | Nov 13, 2026 |
| Raymond James Financial Inc | 279K | 2.1% | new | Nov 12, 2026 |
| Two Sigma | 241K | 1.8% | new | Nov 16, 2026 |
| American Financial Group Inc | 224K | 1.7% | no change | Nov 12, 2026 |
| JPMorgan | 202K | 1.5% | +202K | Nov 12, 2026 |
| Captrust Financial Advisors | 201K | 1.5% | new | Nov 12, 2026 |
| Renaissance Technologies | 134K | 1.0% | +42,733 | Nov 12, 2026 |
| Bank of America | 132K | 0.99% | new | Nov 16, 2026 |
| Geode Capital | 121K | 0.90% | +30,292 | Nov 6, 2026 |